1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Siegal, G. Davis, B. Kristensen, S.M. Sankar, A. Linacre, J. Stein, R.C. Panayotou, G. Waterfield, M.D. Driscoll, P.C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 276 461 478 10.1006/jmbi.1997.1562 9512716 Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase. 1998 10.2210/pdb1bfj/pdb pdb_00001bfj 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 12746.247 P85 ALPHA C TERMINAL SH2 DOMAIN 1 man polymer PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY ALPHA SUBUNIT, PI3-KINASE P85-ALPHA SUBUNIT no no MEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLK ELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR MEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLK ELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n cattle Bos Escherichia Escherichia coli sample BL21 9913 BRAIN Bos taurus 469008 Escherichia coli BL21(DE3) BL21 (DE3) PET-23D BL21 database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1998-02-25 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1997-11-18 REL NO NOE VIOLATION > 0.3A, NO DIHEDRAL VIOLATION > 3.0 100 1 VARIOUS 50 mM 7.5 1 atm 290 K 30 CONFORMERS WERE DETERMINED BY RESTRAINED MOLECULAR DYNAMICS/SIMULATED ANNEALING METHOD USING THE PROGRAM X-PLOR 3.84. THE STRUCTURES ARE BASED ON 1908 INTERPROTON DISTANCE RESTRAINTS DERIVED FROM NOE MEASUREMENTS; 88 HYDROGEN-BONDING DISTANCE RESTRAINTS FOR 44 HYDROGEN-BONDS IDENTIFIED ON THE BASIS OF THE NOE AND AMIDE PROTON EXCHANGE DATA; 25 TORSION ANGLE RESTRAINTS DERIVED FROM COUPLING CONSTANTS AND NOE DATA. THE RMS DISTRIBUTION ABOUT THE MEAN COORDINATE POSITIONS IS 0.57 ANGSTROMS FOR ALL BACKBONE ATOMS AND 1.12 ANGSTROMS FOR ALL ATOMS. THE AVERAGE STRUCTURE WAS THEN CALCULATED BY BEST FIT SUPERPOSITION, COORDINATE AVERAGING AND RESTRAINED ENERGY MINIMIZATION. simulated annealing BRUNGER refinement X-PLOR 3.84 structure solution XPLOR 600 Varian UNITYPLUS n 1 0 A GLU 1 n 2 GLU 1 A ASP 2 n 3 ASP 2 A LEU 3 n 4 LEU 3 A PRO 4 n 5 PRO 4 A HIS 5 n 6 HIS 5 A HIS 6 n 7 HIS 6 A ASP 7 n 8 ASP 7 A GLU 8 n 9 GLU 8 A LYS 9 n 10 LYS 9 A THR 10 n 11 THR 10 A TRP 11 n 12 TRP 11 A ASN 12 n 13 ASN 12 A VAL 13 n 14 VAL 13 A GLY 14 n 15 GLY 14 A SER 15 n 16 SER 15 A SER 16 n 17 SER 16 A ASN 17 n 18 ASN 17 A ARG 18 n 19 ARG 18 A ASN 19 n 20 ASN 19 A LYS 20 n 21 LYS 20 A ALA 21 n 22 ALA 21 A GLU 22 n 23 GLU 22 A ASN 23 n 24 ASN 23 A LEU 24 n 25 LEU 24 A LEU 25 n 26 LEU 25 A ARG 26 n 27 ARG 26 A GLY 27 n 28 GLY 27 A LYS 28 n 29 LYS 28 A ARG 29 n 30 ARG 29 A ASP 30 n 31 ASP 30 A GLY 31 n 32 GLY 31 A THR 32 n 33 THR 32 A PHE 33 n 34 PHE 33 A LEU 34 n 35 LEU 34 A VAL 35 n 36 VAL 35 A ARG 36 n 37 ARG 36 A GLU 37 n 38 GLU 37 A SER 38 n 39 SER 38 A SER 39 n 40 SER 39 A LYS 40 n 41 LYS 40 A GLN 41 n 42 GLN 41 A GLY 42 n 43 GLY 42 A CYS 43 n 44 CYS 43 A TYR 44 n 45 TYR 44 A ALA 45 n 46 ALA 45 A CYS 46 n 47 CYS 46 A SER 47 n 48 SER 47 A VAL 48 n 49 VAL 48 A VAL 49 n 50 VAL 49 A VAL 50 n 51 VAL 50 A ASP 51 n 52 ASP 51 A GLY 52 n 53 GLY 52 A GLU 53 n 54 GLU 53 A VAL 54 n 55 VAL 54 A LYS 55 n 56 LYS 55 A HIS 56 n 57 HIS 56 A CYS 57 n 58 CYS 57 A VAL 58 n 59 VAL 58 A ILE 59 n 60 ILE 59 A ASN 60 n 61 ASN 60 A LYS 61 n 62 LYS 61 A THR 62 n 63 THR 62 A ALA 63 n 64 ALA 63 A THR 64 n 65 THR 64 A GLY 65 n 66 GLY 65 A TYR 66 n 67 TYR 66 A GLY 67 n 68 GLY 67 A PHE 68 n 69 PHE 68 A ALA 69 n 70 ALA 69 A GLU 70 n 71 GLU 70 A PRO 71 n 72 PRO 71 A TYR 72 n 73 TYR 72 A ASN 73 n 74 ASN 73 A LEU 74 n 75 LEU 74 A TYR 75 n 76 TYR 75 A SER 76 n 77 SER 76 A SER 77 n 78 SER 77 A LEU 78 n 79 LEU 78 A LYS 79 n 80 LYS 79 A GLU 80 n 81 GLU 80 A LEU 81 n 82 LEU 81 A VAL 82 n 83 VAL 82 A LEU 83 n 84 LEU 83 A HIS 84 n 85 HIS 84 A TYR 85 n 86 TYR 85 A GLN 86 n 87 GLN 86 A HIS 87 n 88 HIS 87 A THR 88 n 89 THR 88 A SER 89 n 90 SER 89 A LEU 90 n 91 LEU 90 A VAL 91 n 92 VAL 91 A GLN 92 n 93 GLN 92 A HIS 93 n 94 HIS 93 A ASN 94 n 95 ASN 94 A ASP 95 n 96 ASP 95 A SER 96 n 97 SER 96 A LEU 97 n 98 LEU 97 A ASN 98 n 99 ASN 98 A VAL 99 n 100 VAL 99 A THR 100 n 101 THR 100 A LEU 101 n 102 LEU 101 A ALA 102 n 103 ALA 102 A TYR 103 n 104 TYR 103 A PRO 104 n 105 PRO 104 A VAL 105 n 106 VAL 105 A TYR 106 n 107 TYR 106 A ALA 107 n 108 ALA 107 A GLN 108 n 109 GLN 108 A GLN 109 n 110 GLN 109 A ARG 110 n 111 ARG 110 A ARG 111 n 112 ARG 111 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O LEU 34 A O LEU 35 A N SER 47 A N SER 48 A O TYR 44 A O TYR 45 A N ILE 59 A N ILE 60 1 A MET 0 A MET 1 1 Y 1 A A O H GLU ASN 8 12 1.39 1 A A HE O ARG GLU 36 37 1.40 1 A A O H TRP VAL 11 35 1.56 1 A A O H TYR ILE 44 59 1.58 1 A SER 15 -92.54 44.74 1 A SER 39 118.15 -103.62 1 A ASP 51 -49.85 -10.96 1 A TYR 66 64.25 -17.23 1 A VAL 91 -23.93 -43.87 1 A GLN 92 -55.35 175.27 1 A ASN 94 119.67 -12.53 1 A ASP 95 58.42 11.40 model building X-PLOR 3.84 refinement X-PLOR 3.84 phasing X-PLOR 3.84 SOLUTION STRUCTURE OF THE C-TERMINAL SH2 DOMAIN OF THE P85ALPHA REGULATORY SUBUNIT OF PHOSPHOINOSITIDE 3-KINASE, NMR, MINIMIZED AVERAGE STRUCTURE 1 Y N A PRO 4 A PRO 5 HELX_P A HIS 6 A HIS 7 5 1 3 A GLU 8 A GLU 9 HELX_P A TRP 11 A TRP 12 1 2 4 A ARG 18 A ARG 19 HELX_P A LEU 25 A LEU 26 1 3 8 A LEU 78 A LEU 79 HELX_P A HIS 87 A HIS 88 1 4 10 SH2 DOMAIN SH2 DOMAIN, P85ALPHA, PI 3-KINASE, C TERMINAL SH2 DOMAIN P85A_BOVIN UNP 1 1 P23727 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEAKPEEIGWLNGYNETTGERGDFPGTYVEYIGRK KISPPTPKPRPPRPLPVAPGPSKTEADSEQQASTLPDLAEQFAPPDVAPPLLIKLVEAIEKKGLECSTLYRTQSSSNPAE LRQLLDCDTASLDLEMFDVHVLADAFKRYLLDLPNPVIPVAVSSELISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTL QYLLKHFFKLSQTSSKNLLNARVLSELFSPLLFRFPAASSENTEHLIKIIEILISTEWNERQPAPALPPKPPKPTTVANN GMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFNS VVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEDYTRTSQEIQMK RTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNETEIQRIMHNYEKLKSRISEIVDSRRRLEEDLKKQAAEYREID KRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRG KRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYA QQRR 614 724 1BFJ 1 111 P23727 A 1 2 112 3 anti-parallel anti-parallel A PHE 33 A PHE 34 A GLU 37 A GLU 38 A TYR 44 A TYR 45 A VAL 49 A VAL 50 A VAL 54 A VAL 55 A ILE 59 A ILE 60 1 P 1